Early detection of smoking related chronic obstructive pulmonary disease in Viet Nam;Détection précoce de la bronchopneumopathie chronique obstructive post-tabagique au Viet Nam

Revue des Maladies Respiratoires

Volumn 26, Issue 3, 2009, Pages 267-274

  Duong Quy, S ^a,b,e   Hua Huy, T ^b   Mai Huu Thanh, B ^a   Doan Thi Quynh, N ^a   Le Quang, K ^a   Nguyen Van, H ^a   Phan Van, D ^c   Tran Dinh, H ^a   Reboud, P ^d   Dinh Xuan, A T ^b,d   Homasson, J P ^d  

^a Collège de Médecine de Lam Dong ^*  (Viet Nam)

^b Hôpital Cochin ^*  (France)

^c Service de Pneumo phtisiologie   (Viet Nam)

^d Association Franco Vietnamienne de Pneumologie   (France)

^e NONE   (France)

Author keywords

COPD; Da Lat; Piko 6; Tobacco; Viet Nam

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTIVE VALIDITY; PREVALENCE; SENSITIVITY AND SPECIFICITY; SMOKING; SPIROMETRY; VIET NAM;

EID: 65349131945     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(09)72583-5     Document Type: Article

References (23)

1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S : Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006 ; 27 : 397-412.
2. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Laneet 1997 ; 349 : 1498-504.
3. World Health Organization: World Health Report 2002. Geneva, Switzerland : WHO, 2002. www.who.int/whr/2002.
4. Tan WC, Seale P, Charoenrantakul S, Hardiarto M, Ip M, Mahayiddin A, Zhong NS, Schau B, Iqbal A : Chronic obstructive pulmonary disease (COPD) prevalence in 7 Asian countries: projections based on the COPD prevalence model. Am J Respir Crit Care Med 2001 ; 163 : A81.
5. Ministry of Health of Vietnam and General Statistic Office. Results of the Vietnam national health survey 2001-2002.
6. Chau NQ : Pattern of chronic obstructive pulmonary diseases of patients hospitalized at Bach Mai hospital. J Med Inform 2003 ; 21 : 35-9.
7. Sy DQ, Thanh Binh MH, Quoc NT, Hung NV, Quynh Nhu DT, Bao NQ, Khiet LQ, Hai TD, Raffard M, Aelony Y, Homasson JP : Prevalence of asthma and asthma-like symptoms in Da Lat Highlands, Vietnam. Singapore Med J 2007 ; 48 : 294-303.
8. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J : Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 ; 176 : 532-55.
9. Édition Française de la série « standardisation des explorations fonctionnelles respiratoires » du groupe de travail ATS/ERS. Coordonnée par C. Straus et T. Similowski. Rev Mal Respir 2006 ; 23 : 17S3.
10. Regional COPD Working Group: COPD prevalence in 12 Asia- Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003 ; 8 : 192-8.
11. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P : Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007 ; 176 : 753-60.
12. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C : COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004 ; 9 : 458-65.
13. Liu SM, Wang XP, Wang DL, Zhou YM, Lu JC, Zheng JP, Zhong NS, Ran PX : Epidemiologic analysis of COPD in Guangdong Province. Zhonghua Yi Xue Za Zhi 2005 ; 85 : 747-52.
14. Omori H, Nonami Y, Mithara S, Marubayashi T, Morimoto Y, Aizawa H : Prevalence of airflow limitation in medical check-up in Japanese subjects. J Voeh 2007 ; 29 : 209-19.
15. General Statistical Office. Vietnam statistic year book. Hanoi 2000.
16. Ross H, Trung DV, Phu VX : The costs of smoking in Vietnam: the case of inpatient care. Tobacco Control 2007 ; 16 : 405-9.
17. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thune MJ, Connelle C, Jemale A, Lee TA, Miravitlles M, Aldington S, Beasley R : Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006 ; 27 : 188-207.
18. Swanney MP, Jensen RL, Crichton DA, Beckert LE, Cardno LA, Crapo RO : FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000 ; 162 : 917-9.
19. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W: Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J 2006 ; 27 : 378-83.
20. Collectif Capital Souffle. Capital Souffle : résultats d'une campagne de sensibilisation à la mesure du souffle menée en France en 2005. Presse Med 2007 ; 36 : 824-31.
21. Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W: FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of aiway obstruction and restriction. Chest 2005 ; 127 : 1560-4.
22. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM : Global burden of COPD : systematic review and meta-analysis. Eur Respir J 2006; 28 : 523-32.
23. Chan Yeung M, Ho AS, Cheung AH, Liu RW, Yee WK, Sin KM, Wong MM, Lam CW, Chan KS : Hong Kong Thoracic Society COPD Study Group. Determinants of COPD in Chinese patients in Hong Kong. Int J Tuberc Lung Dis 2007 ; 11 : 502-7.